GLOW (GHK-Cu + BPC-157 + TB-500 blend)

GLOW is a research-peptide blend that combines GHK-Cu, BPC-157 and TB-500 in a single vial. The “glow” nickname points to GHK-Cu’s reputation in skin and collagen research, layered on top of the BPC-157 + TB-500 recovery pairing also known as “Wolverine.” GLOW is a combination, not a single molecule, and like every blend it has no blend-specific clinical trials — the evidence is per-component.

What is the GLOW blend?

The GLOW blend is a combination of separate research peptides supplied pre-mixed in a single vial, sold under the GLOW nickname. It is not an approved drug, not a single molecule, and has no molecular formula, molecular weight or sequence of its own — each of those belongs to the individual compounds inside it. Because it is a blend, the most reliable information lives on the component pages, which this page links to throughout.

What is in it, and what each part contributes

• GHK-Cu — a copper tripeptide studied for collagen remodeling, skin quality and wound repair.
• BPC-157 — a “body protection compound” studied for tendon, ligament, muscle and gut-lining repair.
• TB-500 — a thymosin beta-4 fragment studied for cell migration, angiogenesis and broad soft-tissue repair.

Follow any component link above for its verified data — formula, molecular weight, sequence, mechanism, the research evidence, and storage. This page only summarizes how they are combined.

How the components are stacked

GLOW takes the BPC-157 + TB-500 recovery base and adds GHK-Cu, a copper peptide studied for collagen remodeling and skin quality. The rationale behind the stack is to combine a skin/cosmetic angle with systemic soft-tissue repair interest in one preparation. The exact ratio of the three components varies between sources.

What the evidence shows

There are no human clinical trials of the GLOW blend itself. Blends are marketed combinations, not studied drug products, so there is no trial data for the specific mixture or its ratios. The available evidence is per-component and largely preclinical (cell and animal studies), and you can review it on each compound’s page. Treat any claim about what the blend “does” with caution: combining compounds does not create new proven effects, and it can complicate interpretation rather than simplify it.

Handling, storage and reconstitution (research context)

• A blend is multiple actives in one vial, so a single volume of bacteriostatic water dilutes every component at once — the concentration math applies to the vial as a whole, and the per-component amounts depend on the (often unpublished) ratio.
• Storage follows the most fragile component: keep lyophilized powder cold and dry; refrigerate reconstituted material and protect it from light; avoid repeated freeze-thaw.
• Because ratios are not standardized, a certificate of analysis should ideally list and verify each compound present.

Our reconstitution calculator handles the vial-level mg/mL math, and IU vs mL explains why a syringe “unit” is a volume mark rather than an amount of peptide — a point that matters even more when several actives share one vial.

Cautions and considerations

• Not a single compound — GLOW is a combination; there is no single approved “GLOW” drug.
• No blend-specific human evidence — data is per-component and mostly preclinical.
• Composition and ratios vary by source — two vials labelled “GLOW” may not contain the same amounts.
• Quality matters — verify identity, purity (HPLC) and endotoxin for each listed compound on a COA.
• Informational only — not medical advice; no dosing protocols are provided here.

Frequently asked questions

Is GLOW a single peptide?

No. It is a blend of 3 separate research peptides combined in one vial, which is why it has no single formula, molecular weight or sequence.

Does the GLOW blend have its own research?

No. There are no clinical trials of the blend itself; the evidence comes from studies of each component, which are largely preclinical.

What are the components of GLOW?

GHK-Cu, BPC-157, TB-500. Each has its own page with verified data.

Why are these peptides combined?

The idea of the stack is to put compounds with complementary studied roles into one preparation. Combining them does not create new proven effects.

Related compounds and further reading

• GHK-Cu
• BPC-157
• TB-500
• How to reconstitute peptides
• Sterile technique
• Browse the full peptide library
• All guides
• IU vs mL: why units are not a dose

For informational use only. Not medical advice; consult a qualified healthcare professional. 21+.